Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Renshen Guipi Wan is a traditional Chinese medicine (TCM) manufactured by Liaoning Jindan Pharmaceutical, based on a classic formula from the Chinese Pharmacopoeia. It is composed of several herbal ingredients, including Panax ginseng, Astragalus membranaceus, and Angelica sinensis, which work synergistically to tonify qi and blood while strengthening the heart and spleen. The medicine is primarily indicated for patients suffering from Heart and Spleen Deficiency, a TCM syndrome characterized by symptoms such as palpitations, insomnia, forgetfulness, physical fatigue, and poor appetite. It is also used to treat conditions like anemia and functional uterine bleeding associated with spleen qi deficiency. The product is approved and marketed in China as an over-the-counter (OTC) or prescription herbal remedy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on renshen guipi wan.